PCA3, a Relatively New Marker for Prostate Cancer
This test might lower the number of biopsies driven by prostate-specific antigen testing. Prostate cancer gene 3 (PCA3) is overexpressed in prostate cancer cells. Its product can be measured in urine specimens collected after digital rectal exams; FDA-approved assays are available for clinical use. To determine how PCA3 might help clinicians decide which patients with […]
read more